The Empire Strikes Back: Delaware Supreme Court Systematically Dismantles Chancery’s Anti-Contractarian Crusade

A Clear Message from Dover to Wilmington: Let Them Contract

For corporate practitioners, the collective sigh of relief emanating from Wilmington this year is palpable. Throughout 2026, the Delaware Supreme Court has engaged in a systematic, unapologetic course correction, reining in a Chancery Court that had grown increasingly hostile to private ordering and bespoke corporate governance.

If you have spent the last two years anxiously reviewing your clients' stockholder agreements or sweating over the enforceability of protective provisions, you can finally breathe. In a stunning trio of decisions—backing founder Ken Moelis, upholding the controversial Senate Bill 21 (S.B. 21), and slashing a massive plaintiff’s fee award in the Tesla director pay litigation—Delaware’s highest court has definitively restored the primacy of contractarianism in American corporate law.

The Moelis Reversal: Freedom of Contract Survives

The most immediate practice-altering development is the Delaware Supreme Court’s reversal of the 2024 Chancery ruling in the Moelis litigation. To understand why this matters, we have to look at the panic the lower court caused.

In 2024, the Chancery Court sent shockwaves through the M&A, private equity, and venture capital bars by invalidating key provisions of a stockholder agreement granting founder Ken Moelis sweeping board-control and veto rights. The Chancery Court reasoned that such broad negative covenants violated Section 141(a) of the Delaware General Corporation Law (Del. Code Ann. tit. 8, § 141(a)), which mandates that the business and affairs of a corporation be managed by or under the direction of its board of directors. The lower court essentially ruled that you cannot contract away the board’s fiduciary discretion, no matter what the stockholders agreed to at the time of investment.

The Delaware Supreme Court has now forcefully rejected that premise. By backing Moelis and reversing the Chancery Court, the high court has affirmed that Section 141(a) is not a blunt instrument to be used to invalidate heavily negotiated stockholder agreements.

The Practitioner's Takeaway: You no longer need to rely exclusively on the certificate of incorporation (which requires board and stockholder approval to amend) to secure fundamental governance rights. The Supreme Court has blessed the use of separate stockholder agreements to lock in founder and lead-investor control, restoring a vital tool to the deal lawyer's toolkit.

S.B. 21 Upheld: A Legislative Shield Validated

The Supreme Court’s pro-business, pro-certainty streak did not end with Moelis. The Court also issued a landmark ruling upholding Delaware’s 2025 corporate-law overhaul, widely known as S.B. 21.

S.B. 21 was the Delaware legislature's direct response to a string of Chancery decisions that made it dangerously easy for plaintiffs to challenge corporate transactions. The overhaul statutorily limits certain stockholder suits by insulating transactions from judicial second-guessing—provided the deal is approved by a fully empowered, independent special committee or by an informed vote of the disinterested public stockholders.

By upholding S.B. 21, the Supreme Court has functionally codified and expanded the cleansing power of the MFW framework (Kahn v. M&F Worldwide Corp., 88 A.3d 635 (Del. 2014)). For practicing lawyers, this is a massive defensive weapon.

Why it matters: If you are structuring a take-private, a controller buyout, or any transaction fraught with conflict-of-interest allegations, the roadmap to dismiss plaintiff strike-suits at the pleading stage is now enshrined in statute and blessed by the Supreme Court. Build your independent committees early, empower them fully, and secure the majority-of-the-minority vote. If you follow the S.B. 21 playbook, the courts will not entertain a plaintiff's hindsight valuation complaints.

Deflating the Plaintiff Bar: The Tesla and J&J Haircuts

To put an exclamation point on its 2026 jurisprudence, the Delaware Supreme Court has also targeted the financial engine driving the recent surge in Chancery litigation: exorbitant plaintiff fee awards and massive damages judgments.

In the Tesla director pay litigation, the Supreme Court took a sledgehammer to the Chancery Court’s $176.1 million fee award, slashing it to $70.9 million. While $70 million is still a handsome payday, the massive reduction signals that the Supreme Court will no longer tolerate the Chancery Court handing out unprecedented windfalls to plaintiffs' firms for corporate governance "benefits" of questionable tangible value.

Similarly, the Supreme Court trimmed Johnson & Johnson’s damages exposure in the Auris Health robotics acquisition dispute. While leaving much of the Chancery Court’s underlying reasoning intact, the high court set aside part of the staggering $1 billion award and remanded it for recalculation.

The Bottom Line for Corporate Practice

The 2026 Delaware Supreme Court docket reads like a point-by-point rebuke of judicial overreach. The message is clear: Delaware remains the preeminent home for American corporations precisely because it values predictability, enforces private contracts, and defers to disinterested stockholder votes.

For corporate lawyers, your mandate has changed from defense to offense. You can confidently draft robust veto rights in stockholder agreements again. You can rely on S.B. 21 to structure bulletproof transactions. And you can assure your boards that the days of the Chancery Court handing out nine-figure plaintiff fees without strict appellate scrutiny are over.

In an era where federal regulators are flexing their muscles—evidenced by the U.S. Supreme Court's June 2026 decision reaffirming the SEC's disgorgement powers—Delaware is ensuring its own house remains a bastion of commercial predictability.